Projects funded by the NCN
DEVELOPMENT OF NEW CLASS PHOTOACTIVATED ANTICANCER-ANTIFUNGAL COMPOUNDS: CONJUGATES OF GOLD NANOPARTICLE-SUPPORTED QUINONE METHIDES-ANTICANCER DRUGS, FOR MULTIMODAL TREATMENT OF URINARY BLADDER TUMORS
2019/33/B/NZ7/01608
Keywords:
QUINONE METHIDE QUINONE OXIMES SYNTHETIC ELECTROCHEMISTRY ANTIFUNGAL ANTIBIOTIC ANTICANCER PROTEIN KINASE BIOISOSTERISM DRUG CANDIDATES PHOTOSENSIBILISATION GOLD NANOPARTICLES MULTIMODAL DRUGS
Descriptors:
- ST4_8: Organic chemistry
- NZ1_1: Molecular biology
- NZ7_14: Pharmacy, pharmacotherapy, pharmacology
Panel:
NZ7 - Diagnostic tools, therapies and public health: public health, epidemiology, environmental health risks and occupational medicine, medical ethics, drug discovery and therapies, pharmacology
Host institution :
Sieć Badawcza ŁUKASIEWICZ - Instytut Farmaceutyczny
woj. mazowieckie
Principal investigator (from the host institution):
Number of co-investigators in the project: 10
Call: OPUS 17 - announced on 2019-03-15
Amount awarded: 2 546 120 PLN
Project start date (Y-m-d): 2020-03-25
Project end date (Y-m-d): 2023-03-24
Project duration:: 36 months (the same as in the proposal)
Project status: Project completed
Project description
Download the project description in a pdf file
Note - project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.